NeuraDiag GmbH develops and manufactures CE-marked medical devices and in-vitro diagnostics for neurological and point-of-care applications. Headquartered in Frankfurt am Main, we serve healthcare providers across Europe and international markets.
Founded in 2018 in Frankfurt am Main, NeuraDiag GmbH was established with a single mission: to bring clinically validated, precision-engineered medical technology to neurological and diagnostic care. Our portfolio spans non-invasive neuromodulation devices and point-of-care in-vitro diagnostics, all CE marked under the EU MDR 2017/745 and EU IVDR 2017/746 frameworks. We work with distributors, hospital procurement teams, and regulatory partners across Europe, Asia, and the Middle East to ensure our technology reaches the clinicians and patients who need it most.
A comprehensive range of medical devices and in-vitro diagnostics spanning Class I through Class IIb (MDR) and Class A through Class C (IVDR).
Transcranial magnetic stimulation device for non-invasive neuromodulation in clinical settings.
Class IIbPortable 32-channel EEG system for ambulatory neurological monitoring.
Class IIaSingle-use pre-gelled electrodes for cardiac monitoring and diagnostics.
Class ILightweight magnification loupes with integrated LED illumination for surgical use.
Class IPoint-of-care cardiac troponin I test for rapid rule-in/rule-out of myocardial infarction.
Class CHandheld glycated haemoglobin analyzer for diabetes monitoring and management.
Class BSimultaneous detection of SARS-CoV-2 and Influenza A/B antigens.
Class BSemi-quantitative urinalysis strips for 10-parameter urine screening.
Class AFor regulatory inquiries, distribution partnerships, or product information, please contact our regulatory affairs team.